{"database": "openregs", "table": "federal_register", "rows": [["2014-10933", "Immune Responses to Enzyme Replacement Therapies: Role of Immune Tolerance Induction; Public Workshop", "Notice", "The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, in cosponsorship with the National Organization for Rare Disorders (NORD), is announcing a 1-day public workshop entitled \"Immune Responses to Enzyme Replacement Therapies: Role of Immune Tolerance Induction.\" Partners and stakeholders planning the workshop also include representatives from academia, industry, and patients. The purpose of this workshop is to provide a forum to discuss the role of immune tolerance induction in patients receiving replacement biological products.", "2014-05-13", 2014, 5, "https://www.federalregister.gov/documents/2014/05/13/2014-10933/immune-responses-to-enzyme-replacement-therapies-role-of-immune-tolerance-induction-public-workshop", "https://www.govinfo.gov/content/pkg/FR-2014-05-13/pdf/2014-10933.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, in cosponsorship with the National Organization for Rare Disorders (NORD), is announcing a 1-day public workshop entitled \"Immune Responses to Enzyme Replacement...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2014-10933"], "units": {}, "query_ms": 62.62243795208633, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}